Over the last 20 years, Dr. Elmaadawi, has been involved in several research trials  for managing medication-resistant depression, bipolar disorder, and other psychiatric disorders.  He was involved in trials for  Esketamine, Ketamine, and TMS  at the Mayo Clinic, where he was graduated from.

He published over 50 research articles, presentations and book chapters. For the  list of Dr. Elmaadawi’ publications.

Dr. Elmaadawi received several awards and recognition for his work. He is a member of many national medical societies, such as the American Psychiatric Association, Clinical TMS society, American Academy of Child and Adolescent Psychiatry, and international Society of ECT and Neuromodulation. He was featured many times in the media and the news regarding his hutting edge treatment.

 Dr. Elmaadawi  provided lectures, seminars, and training courses for physicians, mental health providers,  and medical students across the country and internationally.

Dr. Elmaadawi has an extensive clinical experience in treating medication-resistant mood and anxiety disorders with innovative interventional treatments such as  pharmacogenomic, personalized psychiatric medication, TMS and Ketamine. Many disorders that effectively treated with interventional psychiatry services including; depression, bipolar disorder, PTSD, OCD in adults as well pediatric cognitive problems uch as ADHD and learning disorders, and autism spectrum disorder.